The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $44.20

Today's change+0.36 +0.82%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.
 

Zoetis Inc

NYSE: ZTS
Last

(U.S.) $44.20

Today's change+0.36 +0.82%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

Zoetis Inc up (U.S.)$0.36

Zoetis Inc closed up Friday by (U.S.)$0.36 or 0.82% to (U.S.)$44.20. Over the last five days, shares have gained 1.59% and are currently 2.30% off of the 52-week high. Shares have outperformed the S&P 500 by 22.23% during the last year.

Key company metrics

  • Open(U.S.) $43.80
  • Previous close(U.S.) $43.84
  • High(U.S.) $44.29
  • Low(U.S.) $43.80
  • Bid / Ask-- / --
  • YTD % change+35.21%
  • Volume1,518,039
  • Average volume (10-day)4,190,527
  • Average volume (1-month)3,868,805
  • Average volume (3-month)5,008,686
  • 52-week range(U.S.) $28.14 to (U.S.) $45.24
  • Beta--
  • Trailing P/E39.44×
  • P/E 1 year forward28.79×
  • Forward PEG2.32×
  • Indicated annual dividend(U.S.) $0.33
  • Dividend yield0.75%
  • Trailing EPS(U.S.) $1.12
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.97%

Based on its net profit margin of 11.97%, Zoetis Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014Dec 31, 201312/31/2013
Revenue1,2101,1581,0971,254
Total other revenue--------
Total revenue1,2101,1581,0971,254
Gross profit776745718768
Total cost of revenue434413379486
Total operating expense9729588701,128
Selling / general / administrative394396356438
Research & development939287121
Depreciation / amortization16151515
Interest expense (income), net operating29292930
Unusual expense (income)712136
Other operating expenses, total-8-6-6-6
Operating income238200227126
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax238200227126
Income after tax167139155104
Income tax, total71617222
Net income166136155105
Total adjustments to net income--------
Net income before extra. items166136155105
Minority interest-1-301
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items166136155105
Inc. avail. to common incl. extra. items166136155105
Diluted net income166136155105
Dilution adjustment----0--
Diluted weighted average shares502502501501
Diluted EPS excluding extraordinary itemsvalue per share0.330.270.310.21
Dividends per sharevalue per share0.070.000.070.07
Diluted normalized EPSvalue per share0.340.290.310.27